Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2025-12-24 @ 11:53 AM
NCT ID: NCT06995261
Eligibility Criteria: Inclusion Criteria: * Age ≥18 to ≤ 44 years at enrolment * Planned stimulation in a long luteal GnRH agonist protocol with daily s.c. GnRH-agonist * Planned use of Fd for ovarian stimulation as per SmPC * Serum AMH ≥0.3 ng/ml to ≤4.9 ng/ml measured within12 months prior to treatment * Most recent serum AMH value before start of stimulation not older than 12 months * Planned IVF or ICSI treatment in a first or second attempt with ejaculated or cryopreserved male germ cells, autologous or heterologous, with or without planned genetic testing of the oocytes or embryos * Planned triggering of final oocyte maturation with hCG * Willingness and consent to participate Exclusion Criteria: * Serum AMH value not determined in ELECSYS AMH Plus Immunoassay, ACCESS AMH Advanced (Beckham Coulter) or LUMIPULSE G AMH (Fujirebio) * Most recent serum AMH value before start of stimulation older than 12 months * Serum AMH within 12 months prior to treatment AMH ≤ 0.3 ng/ml or ≥4.9 ng/ml measured within 12 months prior to treatment * Pre-treatment with a combined oral contraceptive "pill" consisting of ethinyl estradiol and a synthetic progestogen or a natural estradiol/progesterone * Anovulatory PCOS syndrome * Women with a contraindication for prescription of Fd treatment * Women undergoing ovarian stimulation for fertility preservation
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 44 Years
Study: NCT06995261
Study Brief:
Protocol Section: NCT06995261